Adaptive Biotechnologies names new CFO, restructures business lines
The Seattle-based biotech is looking to make its two internal businesses more independent from each other......»»
Adaptive Biotechnologies sees FY21 revenue $145M-$155M, consensus $149.93M
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Adaptive Biotechnologies reports Q1 EPS (29c), consensus (41c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
A petition is calling for Jill Biden to undo all of Melania Trump"s changes to the White House Rose Garden
"We want Jill Biden and Doug Emhoff to take this on and restore the Rose Garden to Jackie's original design," the petition said. Members of the media view the renewed White House Rose Garden, August 22, 2020. Erin Scott/Reuters A .....»»
Consumer prices surge by most since August 2012
Consumer prices rose in March by the fastest monthly pace in 8.5 years as the reopening of the economy picked up steam......»»
Adaptive Biotechnologies Corp (ADPT) CEO and Chairman Chad M Robins Sold $627,150 of Shares
Related Stocks: ADPT,.....»»
Adaptive Biotechnologies Corp (ADPT) CFO Chad M Cohen Sold $826,000 of Shares
Related Stocks: ADPT,.....»»
Adaptive Biotechnologies management to meet virtually with BTIG
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Adaptive Biotechnologies Secures FDA EUA For COVID-19 T-Cell Response Test
The FDA issued the Emergency Use Authorization (EUA) to Ad read more.....»»
Adaptive Biotechnologies says FDA issues EUA for T-Detect COVID
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Adaptive Biotechnologies downgraded to Neutral from Buy at Goldman Sachs
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Adaptive Biotechnologies reports Q4 EPS (33c), consensus (29c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Adaptive Biotechnologies: Q4 Earnings Insights
Shares of Adaptive Biotechnologies (NASDAQ:ADPT) fell in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 94.12% year over year to ($0.33), which missed the estimate of ($0.29). read more.....»»
Adaptive Biotechnologies expands collaboration with LabCorp
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Adaptive Biotechnologies launches T-Detect COVID test
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Adaptive Biotechnologies price target raised to $74 from $66 at BTIG
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Q2 Solutions teams with Adaptive Biotechnologies to market immunoSEQ Assay
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Adaptive Biotechnologies withdraws its previously announced guidance
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Adaptive Biotechnologies reports Q1 EPS (25c), consensus (21)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Adaptive, Microsoft to conduct study evaluating T-cells in COVID-19 patients
Shares of Adaptive Biotechnologies Corp. were up 7.5% in premarket trading on Wednesday. The company on Tuesday had announced a virtual clinical study .....»»